senda biosciences careers

CAMBRIDGE, Mass., Jan. 26, 2021 /PRNewswire/ -- Senda Biosciences, a therapeutics platform company creating novel categories of medicines based on a new field of science called Intersystems . Senda Biosciences. Fierce Biotech Names Senda Biosciences a 2021 "Fierce 15" Company. Powered by Madgex Job Board Software. Companies will develop novel therapies for a wide range of metabolic conditions, including obesity, glycemia and liver dysfunction CAMBRIDGE, Mass., Jan. 26, 2021 /PRNewswire/ -- Senda Biosciences, a therapeutics platform company creating novel categories of medicines based on a new field of science called Intersystems Biology, announced today that it has entered into a strategic collaboration . We are creative optimists and we would love for you to consider joining our team. Senda Biosciences 20 Acorn Park Drive, Suite 300 Cambridge, MA 02140. Senda Biosciences, Inc., a biotechnology company harnessing the molecular interactions between humans, plants and bacteria to enable new types of medicines, today announced the appointments of . Developer of therapeutic applications intended for novel treatments of human disease. According to LinkedIn Afrand Kamali started working on 2010, then the employee has changed 3 companies and 3 jobs. 11 Atlas Technical Consultants jobs available in Woburn, MA on Indeed.com. Something went wrong while submitting the form. Mining the connections between humans and non-human species to create new medicines. Sedia Biosciences is a privately held Delaware-registered medical device and diagnostics company founded in 2009 and based in Beaverton, Oregon, USA. This is the Senda Biosciences company profile. "Senda's unique approach to understanding and harnessing the interspecies interactions within each of us as a means to treat and prevent human disease opens up tremendous new opportunities for improving human health," said Guillaume Pfefer, Ph.D., Chief Executive Officer of Senda Biosciences and Partner at Flagship Pioneering."The Senda team has made great progress since launching in late 2020. Senda is pioneering a new research discipline it calls Intersystems Biology, and it will create novel treatments for human disease. The company’s Precision Enteric Medicine™ (PEM™) compounds are based on a deep understanding of the interconnected biology of the microbiome, gut immune system, and enteric nervous system. 78 Biosciences $95,000 jobs available in Boston, MA on Indeed.com. Senda Biosciences is pioneering the field of Intersystems Biology to create novel treatments for human disease. There are over 369 bioscience careers in Cambridge, MA waiting for you to apply! 06.10.21. Intersystems Biology focuses on how molecular connections between plant, bacterial, and human cells—coevolved over millennia—define health and disease. Senda's Intersystems Biology discovery platform, built using new techniques in machine learning and computational biology, has . Apply to Research Scientist, Manufacturing Associate, Manufacturing Technician and more! Posted 11:21:11 PM. Intersystems Biology focuses on how molecular connections between plant, bacterial, and human cells—coevolved over millennia—define health and disease. Fierce Biotech. Senda Biosciences, Inc. is pioneering a new field of medicine called Intersystems Biology. CAMBRIDGE, Mass., June 15, 2021 /PRNewswire/ -- Senda Biosciences, Inc., a biotechnology company harnessing the molecular . The constant molecular exchange between the hundreds of trillions of human and non-human cells within us, such as plant and bacterial cells, defines life as profoundly as our genetics. All content is posted anonymously by employees working at Senda Biosciences. He subsequently completed a clinical fellowship in gastroenterology at the University of California at Los Angeles (UCLA), and a postdoctoral research fellowship at the Howard Hughes Medical Institute, Department of Microbiology and Immunology, UCLA School of Medicine. “I am thrilled to be joining Kintai at this important time in the company’s clinical advancement,” said Dr. Plevy. 617.430.4455. Senda Biosciences is pioneering the field of Intersystems Biology to create novel treatments for human disease. CAMBRIDGE, Mass., Jan. 7, 2021 /PRNewswire/ -- Senda Biosciences, a Flagship Pioneering company creating novel . Open Roles. Email formats & phone numbers of Senda Biosciences 100-200 employees. The company studies the molecular connections between bacterial, botanical and human cells and how they define health and disease to develop novel categories of medicines based on molecular insights into the trillions of interspecies connections, helping . CAMBRIDGE, Mass., Oct. 28, 2020 /PRNewswire/ -- Flagship Pioneering today announced the unveiling of Senda Biosciences, a therapeutics platform company leveraging unprecedented insights into the molecular connections between humans and coevolved nonhuman species. Senda Biosciences, Inc. is pioneering a new field of medicine called Intersystems Biology. Active, Closed, Last funding round type (e.g. CAMBRIDGE, Mass., July 16, 2020 (GLOBE NEWSWIRE) -- Kintai Therapeutics, a pioneer in unlocking the power of the human enteric signaling network and its signals throughout the body to combat disease and promote health, announced today that it is in the initial stages of combining its operations and talent with fellow Flagship Labs-founded company Senda Biosciences. Senior Director/Vice President, Financial Planning & Analysis Cambridge. Contact and general information about Senda Biosciences company, headquarter location in Cambridge, Massachusetts. Kintai believes that its core strength lies in the hearts and minds of its talented employees who keep patients at the center. Apply to Sustainability Consultant, Environmental Scientist, Site Reliability Engineer and more! . 161 Biosciences jobs available in Boston, MA on Indeed.com. Microbiologics. Senda Biosciences Announces Formation of World-Class Scientific Advisory Board. Senda Biosciences, Inc. is pioneering a new field of medicine called Intersystems Biology. Contact LinkedIn Outsmarting complex diseases with more intelligent medicines. Celeste brings decades of global experience overseeing all phases of clinical trials and drug development across multiple therapeutic areas to Senda Biosciences. Mint Venture Partners and Partners Investment are the most recent investors. COVID-19 was inevitably the focus of Fierce 15 last year. The constant molecular exchange between the hundreds of trillions of human and non-human cells within us, such as plant and bacterial cells, defines life as profoundly as our genetics. Prior to joining Senda Biosciences in 2019, Dr. Plevy served as CSO at Synlogic, Inc. and previously led the Gastroenterology Disease Area at Janssen Immunology Research & Development. August 10, 2021 bcbiotech Jobs Comments Off on (Sr) Research Associate, Discovery Platform - Assay Development - SENDA Biosciences - Cambridge, MA Senda's Intersytems Biology discovery platform, built using new techniques in machine learning and computational biology, has been able to generate… CAMBRIDGE, Mass., Jan. 7, 2021 /PRNewswire/ -- Senda Biosciences, a Flagship Pioneering company creating novel categories of medicines based on Intersystems Biology, today announced the formation of its Scientific Advisory Board (SAB). Kintai was founded in 2016 by Flagship Labs, the innovation foundry of Flagship Pioneering. Senda Biosciences. Kintai Therapeutics Announces Appointments of Industry Veterans to its Executive Leadership TeamComplementary biomolecular transfer modalities added to Kintai platform through integration with Flagship's Senda Biosciences - read this article along with other careers information, tips and advice on BioSpace kbridge@kintaitx.com, © 1985 - 2021 BioSpace.com. Their latest funding was raised on Jun 10, 2021 from a Series B round. Senda Biosciences, Inc. is pioneering a new field of medicine called Intersystems Biology. Open Positions view all. With a $55 million boost, Senda Biosciences will . Senda Biosciences is a therapeutics platform company leveraging unprecedented insights into the molecular connections between humans. Senda Biosciences is a therapeutics platform company leveraging unprecedented insights into the molecular connections between humans, plants, and bacteria. Salary. Website: Senda Biosciences. "Senda's unique approach to understanding and harnessing the interspecies interactions within each of us as a means to treat and prevent human disease opens up tremendous new opportunities for improving human health," said Guillaume Pfefer, Ph.D., Chief Executive Officer of Senda Biosciences and Partner at Flagship Pioneering."The Senda team has made great progress since launching in late 2020. ProteinSimple. Biopharmaceuticals Personnel News Release - June 15, 2021 Senda Biosciences Strengthens Leadership Team with Key Management Hires CAMBRIDGE, Mass., June 15, 2021 -- (Healthcare Sales & Marketing Network) -- Senda Biosciences, Inc., a biotechnology company harnessing the molecular interactions between humans, plants and bacteria to enable new types of medicines, today announced the appointments . Senda Biosciences is pioneering the field of Intersystems Biology to create novel treatments for human disease. Departments. Unlike other intelligence solutions, BCIQ exclusively supports the unique needs of the biopharma industry and . Companies. Dr. Plevy is a gastroenterologist and molecular immunologist who, prior to his appointment as CSO of Senda, held leadership positions at Synlogic, Inc. and Janssen Immunology Research & Development, LLC. Current Job Openings G&A. During his career, Dr. Plevy has published over 110 refereed papers, served as the lead investigator on multiple early-phase clinical trials and performed translational research to advance the understanding of novel immunologic interventions in inflammatory bowel disease and other immunologic disorders. OPEN POSITIONS. People…See this and similar jobs on LinkedIn. SaaS, Android, Cloud Computing, Medical Device), Where the organization is headquartered (e.g. Kintai Therapeutics is uniquely focused on unlocking the power of the enteric signaling network and its signals throughout the body to fight disease and restore health. Since its launch in 2000, the firm has applied a unique hypothesis-driven innovation process to originate and foster more than 100 scientific ventures, resulting in over $34 billion in aggregate value. Business Development Manager Cambridge. CAMBRIDGE, Mass., Oct. 28, 2020 /PRNewswire/ -- Flagship Pioneering today announced the unveiling of Senda Biosciences, a therapeutics platform company leveraging unprecedented insights into the . It is establishing a new field and developing an unprecedented platform for the creation of novel medicines. Seed, Series A, Private Equity), General contact email for the organization. “It is truly a rare opportunity to be able to join a team working at the forefront of an entirely new approach to precision therapeutics that elucidates broad implications of enteric biology and microbiology in many human diseases with unmet medical needs. Senda Biosciences Announces Closing of $98 Million Series B Financing. Prior to joining Flagship, he was SVP, Global Vaccine Leader for Shingrix, GSK 's . Genomics. Dr. Pfefer is an experienced life sciences executive who brings a wealth of expertise spanning research and development, manufacturing, strategy, commercial, business development and operations. Biotechnology Set a new standard for yourself, everyday. SENDA Biosciences >> Sr. Senda Biosciences has raised a total of $143M in funding over 2 rounds. CAMBRIDGE, Mass., June 10, 2021 /PRNewswire/ -- Senda Biosciences, a company that is systematically harnessing the powerful . Research. Scientist, Drug Product Development, PDMS in Cambridge, MA Monday 18 October 2021 15:08 | SENDA Biosciences | SENDA Biosciences These therapies will enable new frontiers for medicines, such as programmable tissue targeting beyond the liver for nucleic acid, cell, and gene therapies;… | SENDA Biosciences - Cambridge Prior to joining Senda Biosciences in 2019, Dr. Plevy served as CSO at Synlogic, Inc. and previously led the Gastroenterology Disease Area at Janssen Immunology Research & Development. BioWorld. 206 Biosciences jobs available in Cambridge, MA on Indeed.com. Formulations Research Associate Cambridge. About Senda Biosciences Senda Biosciences is pioneering the field of Intersystems Biology to create novel treatments for human disease. Senti Bio’s mission is to create a new generation of smarter medicines that outmaneuver complex diseases in ways previously inconceivable. Senda Biosciences, Inc. is pioneering a new field of medicine called Intersystems Biology. Senda Biosciences General Information Description. All Current Exited. Your submission has been received! Careers careers@sendabiosciences.com. Funding to accelerate development of its platform and therapeutic programs. We value a diversity of perspectives and creative thinking in order to achieve our ambitious goals. ProteinSimple is a company that provides protein analysis tools. Senda Biosciences Announces Closing of $98 Million Series B Financing. CAMBRIDGE, Mass., Oct. 28, 2020 /PRNewswire/ -- Flagship Pioneering today announced the unveiling of Senda Biosciences, a therapeutics platform company leveraging unprecedented insights into the . Intersystems Biology focuses on how molecular connections among botanical, bacterial, and human cells—coevolved over millennia—define health and disease. Senda Biosciences 20 Acorn Park Drive, Suite 300 Cambridge, MA 02140. Fierce Biotech. No other file types will be accepted. CAMBRIDGE, Mass., October 28, 2020 - Flagship Pioneering today announced the unveiling of Senda Biosciences, a therapeutics platform company leveraging unprecedented insights into the molecular connections between humans and coevolved nonhuman species.Senda is pioneering a new research discipline it calls intersystems biology, and it will create novel treatments for human disease. Senda's Intersytems Biology discovery platform, built using new techniques in. Flagship is an experiment in institutional, entrepreneurial, innovation practiced in the context of a small company with an insurgent mindset. degree and an A.B. All rights reserved. Join Senti Bio and help build the next generation therapeutics. Apply to Production Operator, Customer Specialist, Scientist and more! SOCIAL MEDIA. About Kintai and Senda Pioneering Intersystems Biology. Rubens is a principal at Flagship Pioneering and has cofounded several of the firm's startups. 06.10.21. Prior to GSK, Dr. Pfefer served as President and CEO of Kala Pharmaceuticals, where he helped transform the company from a pre-clinical technology platform start-up to a leading ophthalmology company currently with two commercial products on the market. A free inside look at Senda Biosciences salary trends based on 7 salaries wages for 6 jobs at Senda Biosciences. New bioscience careers in Cambridge, MA are added daily on SimplyHired.com. Our commitment is to become a leader in three areas intended to advance global access to care: state-of-the-art rapid point of care diagnostic assays. CAREERS. Senda Biosciences is pioneering the field of Intersystems Biology to create novel treatments for human disease. Dr. Guillaume Pfefer, CEO-Partner at Flagship Pioneering, and Dr. Scott Plevy, CSO of Senda Biosciences, will serve as CEO and CSO of the newly combined company, respectively. Senda Biosciences, Inc. is pioneering a new field of medicine called Intersystems Biology. Flagship's platform tech firm Senda raises $98M to explore intersystems biology. People are a system of systems—both human and non-human. Through the company’s focus on human biology, experimental medicine, bioinformatics and machine learning, Kintai has created a discovery and therapeutic development approach to identify and deliver new medicines. Kintai has pioneered a new frontier in gut science, resulting in a unique understanding of a wealth of new genes, metabolites, and signaling molecules, leveraging these insights to rapidly translate into a highly actionable pipeline. Senda Biosciences Strengthens Leadership Team with Key Management Hires. CAMBRIDGE, Mass., Jan. 27, 2020 /PRNewswire/ -- Flagship Pioneering, a unique life sciences innovation enterprise, today announced a first-in-category reproductive health company, Ohana Biosciences. Intersystems Biology focuses on how molecular connections between botanical, bacterial, and human cells—coevolved over millennia—define health and disease. Business Area (s): Synthetic Biology. “We are delighted to add the business and scientific expertise and experience of Guillaume and Scott to Kintai’s exceptional executive leadership team,” said John Mendlein, Ph.D., Chairman of the Board of Kintai Therapeutics and Executive Partner of Flagship Pioneering. Co-op: Research Associate, Formulations Cambridge. CAMBRIDGE, Mass., June 15, 2021 /PRNewswire/ -- Senda Biosciences, Inc., a biotechnology company harnessing the molecular interactions between humans, plants and bacteria to enable new types of medicines, today announced the appointments of Matthew Osborne, as Chief . Senda drives 3 programs toward clinic with bumped-up $98M series B. He joined Flagship in 2015 after getting his PhD in microbiology from MIT. Intersystems Biology focuses on how molecular connections between botanical, bacterial, and human cells—coevolved over millennia—define health and disease. Apply to Research Scientist, Manufacturing Associate, Communications Associate and more! Glassdoor gives you an inside look at what it's like to work at Senda Biosciences, including salaries, reviews, office photos, and more. CAMBRIDGE, Mass., June 10, 2021 /PRNewswire/ -- Senda Biosciences, a company that is systematically harnessing the powerful molecular interactions that have evolved over millennia between humans, plants, and bacteria to develop new types of medicines, announced today the completion of a $55 million Series B extension financing, bringing its total Series B funding to $98 million and total . 369 bioscience jobs available in Cambridge, MA. Chief Legal Officer at Senda Biosciences. Senda Biosciences, Inc. is pioneering a new field of medicine called Intersystems Biology. The low-stress way to find your next bioscience job opportunity is on SimplyHired. Clinical focus: Developing new mRNA therapies, genetic medicines and "protein-in-a-pill . 06.10.21. Senda Biosciences Closes $98M Series B Financing Senda Biosciences, a Cambridge, Mass.-based company that harnesses the molecular interactions between humans, plants, and bacteria to develop new types of medicines, raised a $55m Series B extension financing, bringing its total Series B funding to $98m and total funding raised to date to $143m. novel epidemiological disease surveillance . We thank Paul-Peter for his many contributions and look forward to the important contributions Guillaume and Scott will undoubtedly make in harnessing the innovative platform opportunities and expertise of the newly combined Kintai and Senda organization to combat disease and promote health.”. See Our Ecosystem Structure. We're always on the hunt for new benefits that support our people, inside and outside of work. Posted 11:19:10 PM. Apply electronically by submitting your resume and cover letter as RTF, Word, or PDF attachment(s) to jobs@sediabio.com or use the form at the bottom of the page to upload files. Founded in 2019, Senda is developing novel platforms designed to solve the challenges of transferring therapeutic payloads across biological barriers. Senda Biosciences. Guillaume is the Chief Executive Officer of Senda Biosciences and is a Flagship Pioneering CEO-Partner. “I am excited to be joining a team dedicated to translating breakthrough science and technology into new solutions for preventing and treating diseases,” said Dr. Pfefer. Greater Boston Area Startups Founded in 2017. Ohana is embarking on a fresh approach to the field of reproductive medicine with the creation of the industry's first sperm biology platform, a . Proteomics. Senda Biosciences, Inc. is pioneering a new field of medicine called Intersystems Biology. People are a system of systems—both human and non-human. “As the medical community continues to recognize the role of enteric biology in diseases as far ranging as oncology and COVID-19, this is an exciting time to leverage Kintai’s industry first enteric biology and small molecule chemistry platform for generating innovative product candidates with first-in-class mechanisms for a number of therapeutic areas, including metabolic, cancer and neurological diseases. Senda's SAB is composed of leading experts across immunology, microbiology, biochemistry, and neurology, and will collaborate with Senda's leadership to support . For the biopharma industry investment, business development and competitive intelligence professionals who require information to support financing, partnering and licensing activities, BCIQ provides accurate information and context to support profitable and strategic decision making. Never complacent or afraid to be different; developing brand new therapies that don't currently exist, Building and nurturing an inclusive culture that encourages collaboration, Here to make a lasting impact on the lives of patients and their families for generations to come. Fierce Biotech. The power of the Senda platform is illustrated by six preclinical programs in oncology, neurology, chronic disease, and metabolic disease. 617.430.4455 . Apply to Senior Scientist, Scientist, Research Scientist and more! Flagship's platform tech firm Senda raises $98M to explore intersystems biology. People are a system of systems—both human and non-human. Senda Biosciences Strengthens Leadership Team with Key Management Hires. The constant molecular exchange between the hundreds of trillions of human and non-human cells within us, such as plant and bacterial cells, defines life as profoundly as our genetics. I am honored to play a role in helping to bring the promise of Kintai’s Precision Enteric Medicine™ discovery platform to reality.”. CAREER WEBSITE None. Kintai Therapeutics All Departments. San Francisco Bay Area, Silicon Valley), Operating Status of Organization e.g. The subject line of the email should read "Last . Lynette Herscha is former Secretary & General Counsel for Concert Pharmaceuticals, Inc. and former Secretary & Chief Legal Officer of Solid Biosciences, Inc. She received a graduate degree from Boston University School of Law and an undergraduate degree from Boston University. About Flagship Pioneering BioWorld. Fellows Program. Senti Biosciences    2 Corporate Drive, First Floor   South San Francisco, CA 94080. The constant molecular exchange between the hundreds of trillions of human and non-human cells within us, such as plant and bacterial cells, defines life as profoundly as our genetics. Afrand Kamali has been working as a Senior Scientist, Metabolomics and Biomarkers for Senda Biosciences for 1339 days. People are a system of systems—both human and non-human. Intersystems Biology focuses on how molecular connections between botanical, bacterial, and human cells—coevolved over millennia—define health and disease. Senda's SAB is composed of leading experts across immunology, microbiology, biochemistry, and neurology, and will collaborate with Senda's leadership to support . Co-op: Analytical Development Cambridge. People…See this and similar jobs on LinkedIn. Intersystems Biology focuses on how molecular connections between botanical, bacterial, and human cells—coevolved over millennia—define health and disease. in mathematics from Columbia University and completed residency training in internal medicine at Brigham and Women’s Hospital in Boston. People…See this and similar jobs on LinkedIn. domain. Senda can identify, quantify, and locate the molecular . We are driven to create medicines that are programmable, controllable and designed to tackle even the most challenging diseases. Senti's gene circuit platform programs cells to be targeted and responsive to disease states, which enables advanced therapeutics with unprecedented levels of activity and control. The current Flagship ecosystem comprises 41 transformative companies, including Axcella Health, Denali Therapeutics, Evelo Biosciences, Foghorn Therapeutics, Indigo Ag, Kaleido Biosciences, Moderna, Rubius Therapeutics, Sana Biotechnology, Seres Therapeutics, and Syros Pharmaceuticals. $87,419 / yr. machine learning and computational biology, has been able to generate novel, actionable insights into the trillions of interspecies molecular connections in the human body, and harnesses the power of this "pharmacy within us" with novel pharmacological approaches. Senior Scientist salaries - 1 salaries reported. This year, it's pretty much more of the same as we see how the sector has and continues to navigate the pandemic while raising cash . Salaries posted anonymously by Senda Biosciences employees. 142 Nestle 2021 $45,000 jobs available on Indeed.com. SENDA Biosciences. View contacts for Senda Biosciences to access new leads and connect with decision-makers. Senda Biosciences is pioneering the field of Intersystems Biology to create novel treatments for human disease. CAMBRIDGE, Mass., Jan. 7, 2021 /PRNewswire/ -- Senda Biosciences, a Flagship Pioneering company creating novel categories of medicines based on Intersystems Biology, today announced the formation of its Scientific Advisory Board (SAB). Companies. status. Founded in 2019, Senda is developing novel platforms designed to solve the challenges of transferring therapeutic payloads across biological barriers. To date, Flagship is backed by more than $4.4 billion of aggregate capital commitments, of which over $1.9 billion has been deployed toward the founding and growth of its pioneering companies alongside more than $10 billion of follow-on investments from other institutions. CAMBRIDGE, Mass., Oct. 28, 2020 /PRNewswire/ -- Flagship Pioneering today announced the unveiling of Senda Biosciences, a therapeutics platform company leveraging unprecedented insights into the . People are a system of systems—both human and non-human. Flagship Pioneering united its "intersystems biology" efforts under one roof last fall, and, now, that company is gearing up for human trials. Fierce Biotech Names Senda Biosciences a 2021 "Fierce 15" Company. Oops! To learn more, please visit the company’s website at www.kintaitx.com. Dr. Plevy earned both an M.D. Search. The constant molecular exchange between the hundreds of trillions of human and non-human cells within us, such as plant and bacterial cells, defines life as profoundly as our genetics. “With its novel biological insights based on the generation of human sample data and machine learning capabilities and modular chemistry proficiencies, Kintai is ideally positioned to bring transformative medicines to patients suffering from a broad array of metabolic, cancer and neurological diseases. Senda Biosciences, Inc. is pioneering a new field of medicine called Intersystems Biology. $136,819 / yr. Senior Research Associate salaries - 1 salaries reported. I am also enthusiastic about the potential of a company that will meld the resources and expertise of Kintai and Senda and eager to unveil the full potential of this combined organization in due time.”. She is an accomplished leader who has driven the advancement of programs from clinical proof of concept through . He holds a Master’s degree in Chemical Engineering from the National School for Chemical Engineering (Nancy, France), a Ph.D. in Materials Science from Centre National de la Recherche Scientifique (CNRS), France, and an MBA from the Wharton School at the University of Pennsylvania. Kintai’s multidisciplinary expertise and its technology platform has delivered a pipeline of programs across multiple therapeutic areas, including oncology, neurology, metabolic disease and immunology. If you're interested in becoming part of the Senda Biosciences team, but don't see a position available that fits your skillset, please reach out: careers@sendabiosciences.com. Senda Biosciences is pioneering the field of Intersystems Biology to create novel treatments for human disease. Total amount raised across all funding rounds, Total number of Crunchbase contacts associated with this organization, Total number of employee profiles an organization has on Crunchbase, Total number of investment firms and individual investors, Descriptive keyword for an Organization (e.g. Head of Program Management. All Companies. Senda Biosciences.

Examples Of Discourse Foucault, Wear Pronunciation Phonetics, Super Flame Dragon Dragon City Rarity, Iybraesil Painting Guide, Kansas City Chiefs Defense Ranking 2021,